These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 14601095)

  • 1. Single nucleotide polymorphism in fibroblast growth factor receptor 4 at codon 388 is associated with prognosis in high-grade soft tissue sarcoma.
    Morimoto Y; Ozaki T; Ouchida M; Umehara N; Ohata N; Yoshida A; Shimizu K; Inoue H
    Cancer; 2003 Nov; 98(10):2245-50. PubMed ID: 14601095
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The fibroblast growth factor receptor 4 (FGFR4) Arg388 allele correlates with survival in head and neck squamous cell carcinoma.
    da Costa Andrade VC; Parise O; Hors CP; de Melo Martins PC; Silva AP; Garicochea B
    Exp Mol Pathol; 2007 Feb; 82(1):53-7. PubMed ID: 17084840
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FGFR4 Arg388 allele is associated with resistance to adjuvant therapy in primary breast cancer.
    Thussbas C; Nahrig J; Streit S; Bange J; Kriner M; Kates R; Ulm K; Kiechle M; Hoefler H; Ullrich A; Harbeck N
    J Clin Oncol; 2006 Aug; 24(23):3747-55. PubMed ID: 16822847
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ECRG1 and FGFR4 single nucleotide polymorphism as predictive factors for nodal metastasis in oral squamous cell carcinoma.
    Choi KY; Rho YS; Kwon KH; Chung EJ; Kim JH; Park IS; Lee DJ
    Cancer Biomark; 2012-2013; 12(3):115-24. PubMed ID: 23481570
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of a single nucleotide polymorphism in codon 388 of the FGFR4 gene in malignant gliomas.
    Mawrin C; Kirches E; Diete S; Wiedemann FR; Schneider T; Firsching R; Kropf S; Bogerts B; Vorwerk CK; Krüger S; Dietzmann K
    Cancer Lett; 2006 Aug; 239(2):239-45. PubMed ID: 16198476
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The fibroblast growth factor receptor-4 Arg388 allele is associated with gastric cancer progression.
    Ye Y; Shi Y; Zhou Y; Du C; Wang C; Zhan H; Zheng B; Cao X; Sun MH; Fu H
    Ann Surg Oncol; 2010 Dec; 17(12):3354-61. PubMed ID: 20844967
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Telomerase activity and human telomerase reverse transcriptase mRNA expression are correlated with clinical aggressiveness in soft tissue tumors.
    Tomoda R; Seto M; Tsumuki H; Iida K; Yamazaki T; Sonoda J; Matsumine A; Uchida A
    Cancer; 2002 Sep; 95(5):1127-33. PubMed ID: 12209700
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Histopathological re-classification of extremity pleomorphic soft tissue sarcoma has clinical relevance.
    Massi D; Beltrami G; Capanna R; Franchi A
    Eur J Surg Oncol; 2004 Dec; 30(10):1131-6. PubMed ID: 15522563
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic significance of Wilms tumor gene (WT1) mRNA expression in soft tissue sarcoma.
    Sotobori T; Ueda T; Oji Y; Naka N; Araki N; Myoui A; Sugiyama H; Yoshikawa H
    Cancer; 2006 May; 106(10):2233-40. PubMed ID: 16607650
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bone versus soft-tissue sarcomas in the elderly.
    Torigoe T; Terakado A; Suehara Y; Kurosawa H; Yazawa Y; Takagi T
    J Orthop Surg (Hong Kong); 2010 Apr; 18(1):58-62. PubMed ID: 20427836
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytokine and cytokine receptor serum levels in adult bone sarcoma patients: correlations with local tumor extent and prognosis.
    Rutkowski P; Kamińska J; Kowalska M; Ruka W; Steffen J
    J Surg Oncol; 2003 Nov; 84(3):151-9. PubMed ID: 14598359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fibroblast growth factor receptor 4 Gly388 Arg polymorphism is not associated with pre-eclampsia in Turkish women.
    Gunes EG; Pinarbasi E
    J Obstet Gynaecol Res; 2011 Dec; 37(12):1824-7. PubMed ID: 21827571
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cancer progression and tumor cell motility are associated with the FGFR4 Arg(388) allele.
    Bange J; Prechtl D; Cheburkin Y; Specht K; Harbeck N; Schmitt M; Knyazeva T; Müller S; Gärtner S; Sures I; Wang H; Imyanitov E; Häring HU; Knayzev P; Iacobelli S; Höfler H; Ullrich A
    Cancer Res; 2002 Feb; 62(3):840-7. PubMed ID: 11830541
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Periosteal margin in soft-tissue sarcoma.
    Lin PP; Pino ED; Normand AN; Deavers MT; Cannon CP; Ballo MT; Pisters PW; Pollock RE; Lewis VO; Zagars GK; Yasko AW
    Cancer; 2007 Feb; 109(3):598-602. PubMed ID: 17183556
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of a clinically applicable post-surgical classification system for primary retroperitoneal soft-tissue sarcoma.
    van Dalen T; Hennipman A; Van Coevorden F; Hoekstra HJ; van Geel BN; Slootweg P; Lutter CF; Brennan MF; Singer S
    Ann Surg Oncol; 2004 May; 11(5):483-90. PubMed ID: 15078637
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polymorphisms in the hypoxia inducible factor 1-alpha and the impact on the prognosis of early stages of oral cancer.
    Muñoz-Guerra MF; Fernández-Contreras ME; Moreno AL; Martín ID; Herráez B; Gamallo C
    Ann Surg Oncol; 2009 Aug; 16(8):2351-8. PubMed ID: 19449077
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TP53 codon 72 polymorphism associated with prognosis in patients with advanced gastric cancer treated with paclitaxel and cisplatin.
    Kim JG; Sohn SK; Chae YS; Song HS; Kwon KY; Do YR; Kim MK; Lee KH; Hyun MS; Lee WS; Sohn CH; Jung JS; Kim GC; Chung HY; Yu W
    Cancer Chemother Pharmacol; 2009 Jul; 64(2):355-60. PubMed ID: 19052714
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surgical management of soft tissue sarcomas of the hand and foot.
    Lin PP; Guzel VB; Pisters PW; Zagars GK; Weber KL; Feig BW; Pollock RE; Yasko AW
    Cancer; 2002 Aug; 95(4):852-61. PubMed ID: 12209730
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early outcomes of soft tissue sarcomas presenting with metastases and treated with chemotherapy.
    King JJ; Fayssoux RS; Lackman RD; Ogilvie CM
    Am J Clin Oncol; 2009 Jun; 32(3):308-13. PubMed ID: 19433963
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brain, the last fortress of sarcoma: similar dismal outcome but discrepancy of timing of brain metastasis in bone and soft tissue sarcoma.
    Chou YS; Liu CY; Chen WM; Chen TH; Chen PC; Wu HT; Shiau CY; Wu YC; Liu CL; Chao TC; Tzeng CH; Wong TT; Yen CC
    J Surg Oncol; 2011 Dec; 104(7):765-70. PubMed ID: 21714120
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.